Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by <i>CYP2C19</i> metabolizer status: subgroup analysis of the PRINCE trial

Mengyuan Zhou; Weiqi Chen; Yuesong Pan; Yi Lin; Xia Meng; Xingquan Zhao; Liping Liu; Jinxi Lin; Hao Li; Yongjun Wang; Yilong Wang

doi:doi:10.18632/aging.202366

← Back

Research Paper Volume 13, Issue 3 pp 3994—4006

Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial

Figure 3. Inhibition of platelet aggregation (IPA) of Ticagrelor/aspirin therapy as compared with Clopidogrel/aspirin therapy during study time course stratified by metabolizer status.